Search Results - Reske, S.N

Refine Results
  1. 1

    Salvage lymph node dissection with adjuvant radiotherapy for nodal recurrence of prostate cancer by Jilg, C A, Rischke, H C, Reske, S N, Henne, K, Grosu, A-L, Weber, W, Drendel, V, Schwardt, M, Jandausch, A, Schultze-Seemann, W

    Published in The Journal of urology (01-12-2012)
    “…We evaluated the impact of salvage lymph node dissection with adjuvant radiotherapy in patients with nodal recurrence of prostate cancer. By default, nodal…”
    Get more information
    Journal Article
  2. 2

    Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2 by WEBER, Y. G, ROEBLING, R, LEHMANN-HORN, F, MOTTAGHY, F. M, LERCHE, H, KASSUBEK, J, HOFFMANN, S, ROSENBOHM, A, WOLF, M, STEINBACH, P, JURKAT-ROTT, K, WALTER, H, RESKE, S. N

    Published in Neurology (06-04-2010)
    “…Myotonic dystrophy type 1 and 2 (DM1/DM2) are multisystemic diseases with common cognitive deficits beside the cardinal muscular symptoms. We performed a…”
    Get full text
    Journal Article
  3. 3

    Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease by Bangerter, M., Moog, F., Buchmann, I., Kotzerke, J., Griesshammer, M., Hafner, M., Elsner, K., Frickhofen, N., Reske, S. N., Bergmann, .

    Published in Annals of oncology (01-10-1998)
    “…Background: Staging of Hodgkin's disease (HD) is accomplished by a variety of invasive and non-invasive modalities. This prospective study was undertaken to…”
    Get full text
    Journal Article
  4. 4
  5. 5

    [18F]FDG-PET in patients with Alzheimer's disease: marker of disease spread by Bittner, D, Grön, G, Schirrmeister, H, Reske, S N, Riepe, M W

    “…It is not known yet whether temporoparietal glucose hypometabolism in patients with probable Alzheimer's disease (AD) reflects disease severity or different…”
    Get more information
    Journal Article
  6. 6

    Radiosynthesis of carbon-11 labeled 6-methyldopamine ([11C]MeDA) by Al-Momani, E., Zlatopolskiy, B.D., Machulla, H.-J., Reske, S.N., Solbach, C.

    Published in Applied radiation and isotopes (01-08-2012)
    “…A rapid and efficient n.c.a. radiosynthesis of 6-[11C]methyldopamine ([11C]MeDA) using the Stille cross-coupling reaction as a key step was developed. The…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Myeloablative radioimmunotherapy with 188Re-CD66mAb before stem cell transplantation. No increase of proinflammatory cytokine levels of TNF-alpha by Mutschler, J, Steinbach, G, Bunjes, D, Reske, S N, Buchmann, I

    Published in Nuclear medicine (2009)
    “…Tumour necrosis factor-alpha (TNF-alpha) serum levels may increase due to intensive conditioning regimes with high-dose-chemotherapy and total body irradiation…”
    Get more information
    Journal Article
  9. 9

    Radiosynthesis of [[sup.18]F]FEt-Tyr-urea-Glu as a new PSMA ligand by Momani, E. Al, Malik, N, Machulla, H.-J, Reske, S.N, Solbach, C

    “…An efficient radiosynthesis of [[sup.18]F]FEt-Tyr-urea-Glu ([[sup.18]F]FEtTUG) as a new ligand for prostate specific membrane antigen (PSMA) was developed by…”
    Get full text
    Journal Article
  10. 10

    Synthesis of no-carrier-added 6-[[sup.11]C]methyl-L-DOPA by Momani, E. Al, Zlatopolskiy, B.D, Solbach, C, Machulla, H.-J, Reske, S.N

    “…A simple and efficient synthesis of 3,4-dihydroxy-6-[[sup.11]C]methyl-L-phenylalanine ([[sup.11]C]MeDOPA) is described by use of Stille cross-coupling reaction…”
    Get full text
    Journal Article
  11. 11

    New diagnostic imaging procedures in Hodgkin's disease by Bangerter, M., Griesshammer, M., Binder, T., Hafner, M., Heimpel, H., Reske, S.N., Frickhofen, N.

    Published in Annals of oncology (1996)
    “…A variety of new diagnostic imaging methods have been developed in recent years for patients with Hodgkin's disease in an attempt to improve the detection of…”
    Get full text
    Journal Article Conference Proceeding
  12. 12

    Determination of individual organ masses for 90Y-anti-CD66 radioimmunotherapy: Influence on therapy planning by Kull, Thomas, Kletting, P., Reske, S.N., Glatting, Gerhard

    Published in Zeitschrift für medizinische Physik (01-12-2011)
    “…Dosimetry is important in the development of radioactive pharmaceuticals, especially for optimizing radionuclide therapy with respect to risk-benefit analysis…”
    Get full text
    Journal Article
  13. 13

    Synthesis and evaluation of 18F-fluoroethylated benzothiazole derivatives for in vivo imaging of amyloid plaques in Alzheimer's disease by Neumaier, B., Deisenhofer, S., Sommer, C., Solbach, C., Reske, S.N., Mottaghy, F.

    Published in Applied radiation and isotopes (01-06-2010)
    “…Amyloid aggregates play a major role in the development of Alzheimer's disease. Targeting these aggregates by PET probes enables non-invasively the detection…”
    Get full text
    Journal Article
  14. 14

    PET und PET-CT maligner Tumoren des exokrinen Pankreas by Reske, S.N.

    Published in Radiologe (01-02-2009)
    “…Zusammenfassung Adenokarzinome des Pankreas stellen den überwiegenden Teil (>95%) aller malignen Pankreastumoren dar. Sie entstehen aus malignen Entartungen…”
    Get full text
    Journal Article
  15. 15

    Prostatakarzinom by Adamietz, I.A., Czeloth, K., Ganswindt, U., Miller, K., Perner, S., Reske, S.N., Walz, J., Wierecky, J.

    Published in Der Onkologe (01-10-2008)
    “…Zusammenfassung Das Prostatakarzinom ist das häufigste Karzinom des Mannes. Die Anzahl früh entdeckter Tumoren stieg durch intensivierte…”
    Get full text
    Journal Article
  16. 16

    Intraindividual comparison of [11C]acetate and [11C]choline PET for detection of metastases of prostate cancer by Kotzerke, J, Volkmer, B G, Glatting, G, van den Hoff, J, Gschwend, J E, Messer, P, Reske, S N, Neumaier, B

    Published in Nuclear medicine (2003)
    “…In a pilot trial we investigated whether significant differences in prostate cancer (PCA) imaging would be observed using [(11)C]acetate and [(11)C]choline…”
    Get more information
    Journal Article
  17. 17

    Nuklearmedizinische Diagnostik beim Prostatakarzinom: Aktueller Stand by Reske, S.N.

    Published in Urologe. Ausgabe A (01-11-2007)
    “…Das Prostatakarzinom ist die häufigste lebensbedrohliche Tumorerkrankung des Mannes in der westlichen Hemisphäre. In Deutschland muss mit ca. 40.600…”
    Get full text
    Journal Article
  18. 18

    Radiolabeled DNase, a potential indicator for noninvasive detection of tissue damage by Reske, S N, Reske, K, Winkler, C

    Published in European Journal of Nuclear Medicine (01-07-1983)
    “…Pancreatic DNase I was labeled with 131I or fluorescamine and injected IV into NMRI mice bearing a sarcoma 180. Of the injected tracer, 1.5%-2% was found to…”
    Get full text
    Journal Article
  19. 19
  20. 20